Total number of projects: 2
As coordinator: 0
As participant: 2
Sole participant: 0
Coordinator / Participant Ratio: 0*
Total project funding [€]: | Projects [No]: | |||||
---|---|---|---|---|---|---|
Year: | coordinator* | participant* | per partner | as coordinator | as participant | |
2022 | 0 | 6.846.157 | 397.290 | 1 | ||
2021 | 0 | 2.281.840 | 62.700 | 1 |
Total number of partners: 40
Partner loyalty:
Frequent Partner: (> 2 projects): 0
Rare Partner: 40
Frequent / Rare Partner Ratio: 0
Start date | Project | acronym | role | funding | partners |
---|---|---|---|---|---|
2022-07-01 | SARS-CoV-2-induced activation of pathogenic endogenous retrovirus envelope HERV-W: towards personalized treatment of COVID-19 patients | HERVCOV | participant | 6.846.157 | 9 |
2021-01-01 | Establishing international standards in the analysis of patient reported outcomes and health-related quality of life data in cancer clinical trials | SISAQOL-IMI | participant | 2.281.840 | 33 |